NewGenIvf Group Limited Warrants closed at $0.02 on Sep 28, unchanged, 54.0% below its highest close since Apr 4. Volume of 7.0K shares was 0.70× its 20-day average (below normal).
Split-adjusted performance: -0.5% over six months.
Short interest was 2.6K shares at the Sep 15 settlement, down 18.8% from the prior report (1.0 days to cover).
NewGenIvf Group Ltd is a tech-forward, diversified, multi-jurisdictional entity capitalizing on emerging opportunities across real estate development, digital asset innovation, and reproductive health solutions. The company offers two services, namely: in vitro fertilization (IVF) treatment service, comprising traditional IVF and egg donation; and fertility referral services, like surrogacy and ancillary caring services.
What is NIVFW's market cap?
$160.58K, based on the Sep 28 close of $0.02.
About NewGenIvf Group Limited Warrants
NewGenIvf Group Ltd is a tech-forward, diversified, multi-jurisdictional entity capitalizing on emerging opportunities across real estate development, digital asset innovation, and reproductive health solutions. The company offers two services, namely: in vitro fertilization (IVF) treatment service, comprising traditional IVF and egg donation; and fertility referral services, like surrogacy and ancillary caring services. It derives maximum revenue from in vitro fertilization (IVF) treatment service. Its Geographical presence is in China / HK SAR, Thailand, Cambodia, U.S and Kyrgyzstan. The company derives maximum revenue from Kyrgyzstan.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology